These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 18401471)

  • 1. Statins and primary prevention: is all the evidence in?
    Rashid S; Francis GA
    Can J Cardiol; 2008 Apr; 24(4):301-3. PubMed ID: 18401471
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical and public health assessment of benefits and risks of statins in primary prevention of coronary events: resolved and unresolved issues.
    Moride Y; Hegele RA; Langer A; McPherson R; Miller DB; Rinfret S
    Can J Cardiol; 2008 Apr; 24(4):293-300. PubMed ID: 18401470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comment from tHE cardiologic-angiologic viewpoint].
    Rosemann A
    Praxis (Bern 1994); 2011 Jul; 100(14):857-8. PubMed ID: 21732298
    [No Abstract]   [Full Text] [Related]  

  • 4. The statin era: in search of the ideal lipid regulating agent.
    Shepherd J
    Heart; 2001 Mar; 85(3):259-64. PubMed ID: 11179260
    [No Abstract]   [Full Text] [Related]  

  • 5. Statins in the era of evidence-based medicine--who will not "prosper"?
    McDougall C; Perry CG; Sattar N; Petrie JR
    Scott Med J; 2003 Aug; 48(3):64-8. PubMed ID: 12968509
    [No Abstract]   [Full Text] [Related]  

  • 6. [Lower, lower, lower. The LDL goal value of 200 mg/dl is still much too high].
    Einecke D
    MMW Fortschr Med; 2004 Mar; 146(13):4-5. PubMed ID: 15219114
    [No Abstract]   [Full Text] [Related]  

  • 7. [Statins in primary prevention of coronary heart disease].
    Paulweber B
    Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Coronary heart disease patient after myocardial infarct. Must LDL cholesterol now be reduced to 70 mg/dl?]].
    MMW Fortschr Med; 2005 Dec; 147(49-50):17-8. PubMed ID: 16401004
    [No Abstract]   [Full Text] [Related]  

  • 9. [Statins in primary prevention - a must for the general practitioner?].
    Zoller M
    Praxis (Bern 1994); 2011 Jul; 100(14):859-60. PubMed ID: 21732299
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.
    Baigent C; Keech A; Kearney PM; Blackwell L; Buck G; Pollicino C; Kirby A; Sourjina T; Peto R; Collins R; Simes R;
    Lancet; 2005 Oct; 366(9493):1267-78. PubMed ID: 16214597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lowering cholesterol for prevention of myocardial infarct and stroke? MRC/BHF Heart Protection Study].
    Krone W
    Internist (Berl); 2003 Jun; 44(6):753-4. PubMed ID: 14567113
    [No Abstract]   [Full Text] [Related]  

  • 12. Towards a Paradigm Shift in Cholesterol Treatment. A Re-examination of the Cholesterol Issue in Japan.
    Hamazaki T; Okuyama H; Ogushi Y; Hama R
    Ann Nutr Metab; 2015; 66 Suppl 4():1-116. PubMed ID: 25925499
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy and safety of more intensive lowering of LDL cholesterol.
    Giral P; Moulin P; Rosenbaum D
    Lancet; 2011 Feb; 377(9767):715; author reply 715-6. PubMed ID: 21353895
    [No Abstract]   [Full Text] [Related]  

  • 14. Updated guidelines support even lower cholesterol levels for at-risk patients.
    Levenson D
    Rep Med Guidel Outcomes Res; 2004 Aug; 15(15):1, 6-7. PubMed ID: 15320342
    [No Abstract]   [Full Text] [Related]  

  • 15. Overlap analysis of the West of Scotland coronary prevention study (WOSCOPS).
    Lim PO; Yee KM
    Circulation; 1999 Aug; 100(6):686. PubMed ID: 10441109
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prognostic implictions of the lack of a lipid-lowering strategy].
    Baessler A; Fischer M; Hubauer U; Stark K; Hengstenberg W; Wiedmann S; Neureuther K; Holmer S; Mayer B; Schunkert H; Hengstenberg C
    MMW Fortschr Med; 2006 Nov; 148(44):38. PubMed ID: 17619439
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy and safety of cholesterol-lowering treatment.
    Law M; Wald NJ
    Lancet; 2006 Feb; 367(9509):469-70; author reply 470-1. PubMed ID: 16473115
    [No Abstract]   [Full Text] [Related]  

  • 18. ["No infarct without elevated LDL cholesterol"!].
    Greten H
    MMW Fortschr Med; 2008 Nov; 150(48):119. PubMed ID: 19125517
    [No Abstract]   [Full Text] [Related]  

  • 19. Lipid lowering in acute coronary syndromes: new evidence, new questions.
    Schwartz GG; Olsson AG
    Curr Atheroscler Rep; 2002 Jan; 4(1):1-3. PubMed ID: 11772415
    [No Abstract]   [Full Text] [Related]  

  • 20. Reduction of new coronary events and new atherothrombotic brain infarction in older persons with diabetes mellitus, prior myocardial infarction, and serum low-density lipoprotein cholesterol >/=125 mg/dl treated with statins.
    Aronow WS; Ahn C; Gutstein H
    J Gerontol A Biol Sci Med Sci; 2002 Nov; 57(11):M747-50. PubMed ID: 12403804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.